CO
CombiGene Stock: price and insider trades · Sweden
ISIN SE0011616382SE·
No insider purchase over the last 90 days. The latest, by Lars-Peter Ekolind, was filed 14 Nov 2023.
CombiGene: what insiders have been doing
We have very little insider data for CombiGene so far: the most recent filing dates from 14 November 2023. With so few records, no pattern can be drawn yet. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€8,493
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 14 November 2023
Declarations3 total
- 37,366 shares@ SEK 2.64100.0% of flowAktieISIN SE0016101935FI:csv-b03adb59350626c18927Canonical exit: 12 Feb 2024 (T+90)
- 40,000 shares0AktieISIN SE0006504593FI:csv-53e95b3bb59c77512fd5
- 88,888 shares@ SEK 0.45100.0% of flowBTA (betald tecknad aktie)ISIN SE0015661186FI:csv-a3b623eb5afb77fed757
3 of 3 declarations
About CombiGene
CombiGene is a biopharmaceutical company focused on developing gene therapies for the treatment of neurological diseases. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations